Detalhe da pesquisa
1.
Conformation-dependent recognition of HIV gp120 by designed ankyrin repeat proteins provides access to novel HIV entry inhibitors.
J Virol
; 87(10): 5868-81, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23487463
2.
Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization.
Nat Commun
; 12(1): 6705, 2021 11 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34795280
3.
CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristics.
PLoS Pathog
; 4(7): e1000109, 2008 Jul 25.
Artigo
Inglês
| MEDLINE | ID: mdl-18654624
4.
MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1.
J Exp Med
; 208(3): 439-54, 2011 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-21357743
5.
HIV sensitivity to neutralization is determined by target and virus producer cell properties.
AIDS
; 23(13): 1659-67, 2009 Aug 24.
Artigo
Inglês
| MEDLINE | ID: mdl-19581791
6.
Divergent effects of cell environment on HIV entry inhibitor activity.
AIDS
; 23(11): 1319-27, 2009 Jul 17.
Artigo
Inglês
| MEDLINE | ID: mdl-19579289